Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma

Zing Natalia Pin Chuen; Fischer Thais; Zain Jasmine; Federico Massimo; Rosen Steven T.

首页> 外文期刊>Oncology >Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma

【24h】

Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma

机译：外周T细胞淋巴瘤：将新的发展掺入诊断，预后和治疗到临床实践第2部分：ENKTL，EAKTL，EATL，惰性T细胞LDP，ATLL和肝瓣T细胞淋巴瘤

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The World Health Organization classification for peripheral T-cell lymphomas (PTCLs) continues to evolve based on genetic and clinical distinctions of each entity. In Part 1, an overview was provided of PTCL not otherwise specified, follicular T-cell lymphoma, angioimmunoblastic T-cell lymphoma, anaplastic large cell lymphoma (ALCL), and breast implant-associated ALCL. In Part 2, this review is extended to extranodal natural killer (NK)/T-cell lymphoma, enteropathy-associated T-cell lymphoma, indolent T-cell lymphoproliferative disorder of the gastrointestinal tract, adult T-cell leukemia/lymphoma, and hepatosplenic T-cell lymphoma. Each NK/T-cell malignancy has its own signature, requiring knowledge of the appropriate diagnostic, prognostic, and therapeutic considerations when caring for afflicted individuals. Future directions will depend on discoveries that further our understanding of each disease and clinical trials that test the latest treatment options.

机译：世界卫生组织对外周T细胞淋巴瘤（PTCLS）的分类继续基于每个实体的遗传和临床区别而发展。在第1部分中，提供了PTCL未另外规定的PTCL，卵泡T细胞淋巴瘤，血管免疫细胞淋巴瘤，血管痉挛大细胞淋巴瘤（ALCL）和乳腺植入物相关ALCL的概述。在第2部分中，本综述扩展到外骨天然杀伤（NK）/ T细胞淋巴瘤，肠病相关的T细胞淋巴瘤，胃肠道的惰性T细胞淋巴淋巴瘤，成人T细胞白血病/淋巴瘤和肝瓣 T细胞淋巴瘤。每个NK / T细胞恶性肿瘤都有自己的签名，需要了解在照顾受折磨的人时适当的诊断，预后和治疗考虑。未来的方向取决于发现，进一步了解测试最新治疗方案的每种疾病和临床试验。

著录项

来源
《Oncology》 |2018年第8期|共7页
作者
Zing Natalia Pin Chuen; Fischer Thais; Zain Jasmine; Federico Massimo; Rosen Steven T.;
展开▼
作者单位

Santa Casa Sao Paulo Med Sch Dept Med Sao Paulo Brazil;

Santa Casa Sao Paulo Med Sch Dept Med Sao Paulo Brazil;

City Hope Natl Med Ctr Dept Hematol &

Hematopoiet Cell Transplantat 1500 E Duarte Rd Duarte CA;

Univ Modena &

Reggio Emilia Dept Diagnost Clin &

Publ Hlth Med Emilia Romagna Italy;

City Hope Natl Med Ctr Dept Hematol &

Hematopoiet Cell Transplantat 1500 E Duarte Rd Duarte CA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma [J] . Zing Natalia Pin Chuen, Fischer Thais, Zain Jasmine, Oncology . 2018,第8期

机译：外周T细胞淋巴瘤：将新的发展掺入诊断，预后和治疗到临床实践第2部分：ENKTL，EAKTL，EATL，惰性T细胞LDP，ATLL和肝瓣T细胞淋巴瘤
2. Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice [J] . Zing Natalia Pin Chuen, Fischer Thais, Zain Jasmine, Oncology . 2018,第7期

机译：外周T细胞淋巴瘤：将诊断，预测和治疗掺入临床实践的新发展
3. Changing the paradigms of treatment in peripheral T-cell lymphoma: From biology to clinical practice [J] . OConnorO.A., BhagatG., GanapathiK., Clinical cancer research: an official journal of the American Association for Cancer Research . 2014,第20期

机译：改变外周T细胞淋巴瘤的治疗方式：从生物学到临床实践
4. New biologic agents for the treatment of cutaneous T-cell lymphoma. [C] . Vittorio CC, Junkins Hopkins JM, McGinnis KS, World Congress on Cancers of the Skin . 2002

机译：用于治疗皮肤T细胞淋巴瘤的新生物剂。
5. Characterization of the Biological and Clinical Relevance of RUNX Genes in Natural Killer/T-Cell Lymphoma [D] . Selvarajan, Viknesvaran 2016

机译：天然杀手/ T细胞淋巴瘤中RUNX基因的生物学和临床意义的表征。
6. A Phase 1 Study of Bortezomib and Romidepsin in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Indolent B-Cell Lymphoma Peripheral T-Cell Lymphoma or Cutaneous T-Cell Lymphoma [O] . Beata Holkova, Victor Yazbeck, Maciej Kmieciak, -1

机译：硼替佐米和罗米地辛在慢性淋巴细胞性白血病/小淋巴细胞性淋巴瘤惰性B细胞淋巴瘤外周性T细胞淋巴瘤或皮肤性T细胞淋巴瘤患者中的1期研究
7. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma [O] . Iqbal, Javeed, Weisenburger, Dennis D, Greiner, Timothy C, 2010

机译：分子特征改善外周T细胞淋巴瘤的诊断和血管免疫母细胞性T细胞淋巴瘤的预后

Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma

摘要

著录项

相似文献

相关主题

期刊订阅